Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Gilead Sciences' cell therapy Kite Pharma has ... It's the second deal in a matter of days for Shoreline, coming after China's BeiGene paid $45 million upfront to harvest the San Diego-based ...

Salesforce stock won an upgrade to buy from TD Cowen, which pointed to momentum for its new artificial intelligence platform.

Rapid advancements in technology and heightened regulatory requirements are propelling growth in the pharma and biotech CRM ...

AstraZeneca and Gilead are both staying tight-lipped over rumoured merger talks, but the consensus among analysts seems to be that there would anyway be little value in such a deal. On Sunday ...

Teva Pharmaceutical Industries Ltd. ADR-1.19% $24.61B ...